Is Ingevity Corporation (NGVT) Overvalued?
We dive into why Ingevity Corporation (NGVT) could be considered overvalued on 2026-08-04, based on AAII’s Value Score and Grade.Michael Rose
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Ingevity Corporation manufactures and sells activated carbon products, derivative specialty chemicals, and engineered polymers in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. It operates through three segments: Performance Materials, Performance Chemicals, and Advanced Polymer Technologies. The Performance Materials segment engineers, manufactures, and sells hardwood-based and chemically activated carbon products for use in gasoline vapor emission control systems in cars, trucks, motorcycles, and boats. This segment also produces other activated carbon products for food, water, beverage, and chemical purification applications. The Performance Chemicals segment consists of road technologies and industrial specialties. This segment’s products are used in pavement construction, pavement preservation, pavement reconstruction and recycling, road markings, agrochemical dispersants, lubricants, certain adhesives, rubber, and other industrial uses. The Advanced Polymer Technologies segment produces caprolactone and caprolactone-based specialty polymers for use in coatings, resins, elastomers, adhesives, bioplastics, and medical devices. It serves automotive parts manufacturers through sales representatives, third-party sales representatives, and distributors. The company was formerly known as WestRock Company, Specialty Chemicals Business and changed its name to Ingevity Corporation in September 2015. Ingevity Corporation was founded in 1964 and is headquartered in North Charleston, South Carolina.
Commentary & Analysis
What You Need to Know About Ingevity Corporation's Q3 Earnings
Ingevity Corporation's fiscal Q3 earnings report was released on Wednesday, July 29. Let's dive in to see if (NGVT) missed or beat analyst's expectations.Michael Rose
Why Ingevity Corporation’s (NGVT) Stock Is Down 5.04%
As of Monday, June 29, Ingevity Corporation’s NGVT share price has dipped by 5.04%, which has investors questioning if this is right time to buy.Michael Rose
Which Is a Better Investment, Eastman Chemical Company or Ingevity Corporation Stock?
Learn more about whether Eastman Chemical Company or Ingevity Corporation is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.Jenna Brashear
Why Ingevity Corporation’s (NGVT) Stock Is Down 5.27%
As of Tuesday, May 12, Ingevity Corporation’s NGVT share price has dipped by 5.27%, which has investors questioning if this is right time to buy.Jenna Brashear
Financial Summary
| Share Statistics | NGVT | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $2,534.7 | $3,677.9 | 58% |
|
| Shares Out (Mil) | 35.3 | 92.2 | 40% |
|
| Institutional Ownership | 99.2% | 76.6% | 85% |
|
| Float (Mil) | 34.1 | 118.5 | 38% |
|
| Beta | 1.18 | 0.85 | 69% |
|
| Avg Daily Volume (000s) | 395 | 169 | 54% |
|
| Price Change (52-week) |
36.9% | 79.5% | 79% |
|
| Growth | NGVT | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | (0.8%) | 3.8% | 16% |
|
| Net Income (5yr) | (23.9%) | 0.7% | 17% |
|
| EPS (5yr) | (25.0%) | 2.0% | 11 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | (31.3%) | (15.4%) | 18% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 3 | 3 | 3 | |
| Current EPS | $1.587 | $5.243 | $6.013 | |
| Month Ago EPS | $1.593 | $5.243 | $6.013 | |
| # Rev Up | 1 | 1 | 1 | |
| # Rev Down | 0 | 1 | 1 | |
| Three Months Ago EPS | $1.593 | $5.243 | $6.013 | |
| Year/Year Chg | 40.4% | (226.3%) | (264.2%) | |
| Financials | NGVT | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $1,160 | $3,554 | 52% |
|
| Net Income (TTM) (Mil) | $54 | $73 | 55% |
|
| EPS (TTM) | $1.521 | $0.400 | 66% |
|
| Operating Cash Flow (TTM) (Mil) | $211 | $370 | 60% |
|
| Net Cash Flow (TTM) (Mil) | $74 | $1 | 74% |
|
| Long-Term Debt (Q1) (Mil) | $1,080 | $1,313 | 67% |
|
| Enterprise Value (Q1) (Mil) | $3,652 | $5,097 | 58% |
|
| Valuation | NGVT | Industry Median |
Percentile (All Stocks) |
|
| P/B | 54.21 | 1.47 | 99% |
|
| P/E | 104.4 | 22.6 | 94% |
|
| Dividend Yield | 0.0% | 1.1% | 0% |
|
| PEG (5yr hist) | na | 1.4 | na |
|
| Ratios | NGVT | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 41.1% | 27.5% | 51% |
|
| Net Margin | 4.7% | 4.0% | 46% |
|
| ROA | 3.2% | 2.5% | 62% |
|
| ROE | 64.4% | 5.3% | 94% |
|
| Liabilities to Assets | 96.9% | 52.8% | 93% |
|
| F-Score | 5 | 5 | na |
|
Ingevity Corporation did not pass any screens on 11/4/2026.
